Peter Kies - 09 Jun 2021 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
CFO
Signature
Peter Kies
Issuer symbol
INO
Transactions as of
09 Jun 2021
Net transactions value
-$308,138
Form type
4
Filing time
11 Jun 2021, 16:24:37 UTC
Previous filing
04 Jun 2021
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise $29,700 +13,750 +9.1% $2.16 164,538 09 Jun 2021 Direct
transaction INO Common Stock Sale $337,838 -33,750 -21% $10.01* 130,788 09 Jun 2021 Direct F1, F2
holding INO Common Stock 4,500 09 Jun 2021 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Common Stock Option Options Exercise $0 -13,750 -41% $0.000000 20,000 09 Jun 2021 Common Stock 13,750 $2.16 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 These transactions were executed in multiple trades at prices ranging from $10.00 to $10.04, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.